J7527 Everolimus - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Everolimus

Brand Name:

Afinitor, Afinitor Disperz

Strength:

0.25 mg

HCPCS:

J7527

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Enzyme Inhibitor

Minor Drug Class:

mTOR

Oral (Y/N):

Yes

FDA Approval Year:

2009

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2013

CMS Discontinuation Date:

Status:

In Use